LAKE HILLS PHARMACY FORMULATION
Tirzepatide + L-Carnitine

All content on this page has been clinically reviewed and approved by board-certified physicians.
Multiple randomized controlled trials and systematic reviews
Concentration
100mg L-Carnitine / 10mg Tirzepatide per mL (1-4mL vials) OR 100mg L-Carnitine / 20mg Tirzepatide per mL (3mL vial).
Available Vial Sizes
1mL vial (10mg tirzepatide), 2mL vial (20mg tirzepatide), 3mL vial (30mg tirzepatide), 4mL vial (40mg tirzepatide), 3mL vial - 20mg/mL (60mg tirzepatide)
Route of Administration
Subcutaneous (SC)
Storage
Refrigerate 2-8°C
Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity N Engl J Med. 2022 PMID: 35658024
Frias JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes N Engl J Med. 2021 PMID: 34170647
General Information: Accessible overview for patients and healthcare consumers. Switch to Clinical View for complete medical protocols.
These compounded medications use FDA-approved ingredients and are compounded by Lake Hills Pharmacy under the supervision of licensed pharmacists and physicians. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Lake Hills Pharmacy | Licensed Compounding Pharmacy | Professional Medical Oversight Required